Article info
PDFClinical ethics
Methodological quality and reporting of ethical requirements in phase III cancer trials
- Correspondence to: J J Tuech Service de Chirurgie Digestive, Centre Hospitalier de Mulhouse, E-muller-moenchberg, 20 rue dr Laennec, 68070 Mulhouse cedex 1, France; tuechjch-mulhouse.fr
Citation
Methodological quality and reporting of ethical requirements in phase III cancer trials
Publication history
- Received November 18, 2003
- Accepted March 2, 2004
- Revised February 14, 2004
- First published April 29, 2005.
Online issue publication
April 27, 2016
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Copyright 2005 by the Journal of Medical Ethics
Other content recommended for you
- Reporting guidelines for health care simulation research: Extensions to the CONSORT and STROBE statements
- Assessment of the quality of reporting in randomised controlled trials of acupuncture in the Korean literature using the CONSORT statement and STRICTA guidelines
- Adherence in leading medical journals to the CONSORT 2010 statement for reporting of binary outcomes in randomised controlled trials: cross-sectional analysis
- Quality of reporting of harms in randomised controlled trials of pharmacological interventions for rheumatoid arthritis: a systematic review
- Statistical testing of baseline differences in sports medicine RCTs: a systematic evaluation
- CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials
- Quality of reporting in sports injury prevention abstracts according to the CONSORT and STROBE criteria: an analysis of the World Congress of Sports Injury Prevention in 2005 and 2008
- Reporting of stepped wedge cluster randomised trials: extension of the CONSORT 2010 statement with explanation and elaboration
- Reporting trends of randomised controlled trials in heart failure with preserved ejection fraction: a systematic review
- Reporting quality of randomised controlled trial abstracts among high-impact general medical journals: a review and analysis